Suppresses osteosarcoma cell growth and invasion by affecting the PI3K/AKT pathway; Enhances the sensitivity of osteosarcoma cells to Cisplatin through the GAS5/miR-26b-5p/TP53INP1 axis. This evidence concerns the gene GAS5 and osteosarcoma.